🇺🇸 FDA
Patent

US 7008633

Local regional chemotherapy and radiotherapy using in situ hydrogel

expired A61KA61K31/717A61K31/718

Quick answer

US patent 7008633 (Local regional chemotherapy and radiotherapy using in situ hydrogel) held by The Board of Regents of the University of Texas System expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
61
CPC classes
A61K, A61K31/717, A61K31/718, A61K31/721, A61K31/722